Carsten Laue

Carsten Laue is a seasoned professional in the healthcare and biotechnology sectors, currently serving as Managing Partner at M2Care since January 2024, focusing on developing medtech and digital health startups. As Chairperson of the Board at machineMD, Laue oversees the marketing of an innovative diagnostic device for early detection of neurological disorders. In addition to roles at M2Care and machineMD, Laue has been an expert at Innosuisse since January 2019, enhancing Switzerland's innovation in Life Sciences and Digital Health Solutions. Previous positions include Head of Funding and Community Platform at the Swiss Biotech Association, CEO of Medipol, and business consultant roles for several healthcare firms. Laue holds a PhD in Biomaterials from EPFL and has additional educational credentials from Babson College, ETH Zürich, and Technische Universität Darmstadt.